RhumbLine Advisers’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.86M | Sell |
64,202
-3,705
| -5% | -$176K | ﹤0.01% | 1757 |
|
|
2026
Q1 | $3.5M | Buy |
67,907
+2,013
| +3% | +$141K | ﹤0.01% | 1584 |
|
|
2025
Q4 | $6.08M | Sell |
65,894
-1,306
| -2% | -$125K | ﹤0.01% | 1296 |
|
|
2025
Q3 | $4.99M | Sell |
67,200
-3,555
| -5% | -$360K | ﹤0.01% | 1443 |
|
|
2025
Q2 | $9.18M | Sell |
70,755
-780
| -1% | -$113K | 0.01% | 1089 |
|
|
2025
Q1 | $11.4M | Sell |
71,535
-2,115
| -3% | -$383K | 0.01% | 966 |
|
|
2024
Q4 | $13.7M | Sell |
73,650
-2,918
| -4% | -$566K | 0.01% | 903 |
|
|
2024
Q3 | $16.2M | Buy |
76,568
+40,707
| +114% | +$7.07M | 0.01% | 825 |
|
|
2024
Q2 | $4.8M | Buy |
35,861
+304
| +0.9% | +$57.5K | ﹤0.01% | 1426 |
|
|
2024
Q1 | $7.64M | Sell |
35,557
-3,224
| -8% | -$632K | 0.01% | 1189 |
|
|
2023
Q4 | $7.89M | Sell |
38,781
-469
| -1% | -$76K | 0.01% | 1173 |
|
|
2023
Q3 | $7.79M | Buy |
39,250
+64
| +0.2% | +$16.1K | 0.01% | 1112 |
|
|
2023
Q2 | $12.7M | Sell |
39,186
-791
| -2% | -$226K | 0.01% | 895 |
|
|
2023
Q1 | $9.36M | Buy |
39,977
+1,577
| +4% | +$399K | 0.01% | 989 |
|
|
2022
Q4 | $9.67M | Buy |
38,400
+1,825
| +5% | +$389K | 0.01% | 960 |
|
|
2022
Q3 | $6.49M | Buy |
36,575
+3,679
| +11% | +$739K | 0.01% | 1099 |
|
|
2022
Q2 | $6.01M | Buy |
32,896
+4,123
| +14% | +$822K | 0.01% | 1151 |
|
|
2022
Q1 | $7.39M | Buy |
28,773
+524
| +2% | +$120K | 0.01% | 1101 |
|
|
2021
Q4 | $6.5M | Sell |
28,249
-545
| -2% | -$133K | 0.01% | 1220 |
|
|
2021
Q3 | $6.71M | Buy |
28,794
+931
| +3% | +$194K | 0.01% | 1171 |
|
|
2021
Q2 | $5.38M | Sell |
27,863
-781
| -3% | -$155K | 0.01% | 1386 |
|
|
2021
Q1 | $5.93M | Sell |
28,644
-3,333
| -10% | -$708K | 0.01% | 1315 |
|
|
2020
Q4 | $6.01M | Buy |
31,977
+1,192
| +4% | +$195K | 0.01% | 1245 |
|
|
2020
Q3 | $3.97M | Sell |
30,785
-8,710
| -22% | -$960K | 0.01% | 1303 |
|
|
2020
Q2 | $3.44M | Buy |
39,495
+19,716
| +100% | +$1.52M | 0.01% | 1420 |
|
|
2020
Q1 | $1.19M | Buy |
19,779
+241
| +1% | +$17.8K | ﹤0.01% | 1801 |
|
|
2019
Q4 | $1.45M | Buy |
19,538
+340
| +2% | +$21.9K | ﹤0.01% | 1924 |
|
|
2019
Q3 | $1.17M | Sell |
19,198
-15
| -0.1% | -$988 | ﹤0.01% | 1962 |
|
|
2019
Q2 | $1.17M | Buy |
19,213
+387
| +2% | +$20.9K | ﹤0.01% | 1996 |
|
|
2019
Q1 | $1.07M | Buy |
18,826
+3,642
| +24% | +$197K | ﹤0.01% | 2003 |
|
|
2018
Q4 | $642K | Buy |
15,184
+8,800
| +138% | +$374K | ﹤0.01% | 2186 |
|
|
2018
Q3 | $269K | Sell |
6,384
-440
| -6% | -$20.7K | ﹤0.01% | 2571 |
|
|
2018
Q2 | $243K | Buy |
+6,824
| New | +$220K | ﹤0.01% | 2641 |
|
Other funds holding INSP
SCM
DM
RhumbLine Advisers's INSP Position: Q2 2026 in Review
RhumbLine Advisers reduced its Inspire Medical Systems (INSP) stake by 5.5% in Q2 2026, selling an estimated $176K and leaving 64,202 shares worth $2.86M. The position accounts for ﹤0.01% of the portfolio, ranked #1757.
RhumbLine Advisers first reported a position in INSP in Q2 2018 and has held it in 33 quarters since. The position peaked at $16.2M in Q3 2024. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.
- RhumbLine Advisers held 64,202 shares of Inspire Medical Systems worth $2.86M as of Q2 2026.
- RhumbLine Advisers sold 3,705 Inspire Medical Systems shares in Q2 2026, an estimated $176K.
- Inspire Medical Systems made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1757 holding.
- RhumbLine Advisers first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 33 quarters since.
- RhumbLine Advisers's Inspire Medical Systems position peaked at $16.2M in Q3 2024.
- 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.